Morepen Laboratories Limited — Financials & Forensics
NSE: MOREPENLAB · BSE: 500288 · ISIN: INE083A01026
17 Nov 2026
Add MOREPENLAB to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY21 | FY22 | FY23 | FY24 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹1,188 Cr | ₹1,547 Cr | ₹1,418 Cr | ₹1,690 Cr | ₹1,806 Cr |
| EBITDA | ₹119 Cr | ₹137 Cr | ₹80 Cr | ₹159 Cr | ₹126 Cr |
| EBITDA margin | 10.0% | 8.8% | 5.6% | 9.4% | 7.0% |
| Profit after tax | ₹97 Cr | ₹102 Cr | ₹39 Cr | ₹96 Cr | ₹95 Cr |
Deeper analysis
Recent filings by Morepen Laboratories Limited
-
Update on Credit Rating
14 Nov 2026 · Regulatory Compliance
-
Resignation of Director/KMP/SMP
31 Oct 2026 · Management Change
-
Resignation
31 Oct 2026 · Management Change
-
Copy of Newspaper Publication
28 Oct 2026 · Financial Results
-
Monitoring Agency Report
27 Oct 2026 · Regulatory Compliance
Never miss a filing again
About Morepen Laboratories Limited on Indian Stock Alerts
Indian Stock Alerts tracks Morepen Laboratories Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.